AMS vs LLY
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AMS exhibits severe financial distress, anchored by a weak Piotroski F-Score of 2/9 and a critical liquidity position with a current ratio of 0.76. The company is experiencing a systemic decline, evidenced by a -14.80% YoY revenue contraction and a disastrous -200% YoY EPS growth. Despite a low Price-to-Book ratio of 0.37, the stock is in a technical freefall (0/100 trend) and consistently misses earnings estimates by wide margins. The combination of negative profitability and shrinking top-line growth suggests a value trap rather than a value opportunity.
LLY shows neutral fundamentals based on deterministic rules. Financial strength is weak (F-Score 3/9). Mixed signals with both opportunities and risks present.
Compare Another Pair
Related Comparisons
AMS vs LLY: Head-to-Head Comparison
This page compares American Shared Hospital Services (AMS) and Eli Lilly and Company (LLY) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.